Peptide receptor radionuclide therapy with 177Lu-DOTA-TATE as a promising treatment of malignant insulinoma: a series of case reports and literature review.

Daniela S C MagalhãesI L SampaioG FerreiraP BogalhoD Martins-BrancoR SantosH Duarte

Published in: Journal of endocrinological investigation (2018)

After the start of 177Lu-DOTA-TATE all patients achieved hypoglycaemia symptomatic control and had evident improvement of their quality of life. Three patients showed imagiological improvement suggesting reduced tumour load.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
type diabetes
case report
pet ct
computed tomography
replacement therapy
smoking cessation